Evaluation of Self-Reported Progression and Correlation of Imatinib Dose to Survival in Patients with Metastatic Gastrointestinal Stromal Tumors: An Open Cohort Study

OBJECTIVES: Self-reported progression was evaluated as a predictor of survival in patients with metastatic gastrointestinal stromal tumor (GIST). METHODS: This is a follow-up of an open cohort study of Life Raft Group (LRG) members with a diagnosis of KIT-positive metastatic GIST receiving imatinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Call, Jerry, Scherzer, Norman J., Josephy, P. David, Walentas, Christopher
Formato: Texto
Lenguaje:English
Publicado: Springer US 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846326/
https://www.ncbi.nlm.nih.gov/pubmed/19946763
http://dx.doi.org/10.1007/s12029-009-9111-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846326/
https://www.ncbi.nlm.nih.gov/pubmed/19946763
http://dx.doi.org/10.1007/s12029-009-9111-x

Ejemplares similares